Esophageal Cancer Prevention
Esophageal Cancer Prevention
This is one of the few gastrointestinal cancers with a detectable and treatable precursor, so screening is genuinely useful — but only in the groups whose risk makes it worthwhile. For everyone else the useful measures are tobacco, alcohol and the temperature of drinks.
Why screening is worth doing here
Screening is only justified when it can find a disease early enough to change what happens to the person who has it, and oesophageal cancer satisfies that condition better than most cancers do.
- There is a treatable precursor — high-grade dysplasia in squamous mucosa and dysplasia in Barrett's mucosa can both be removed before an invasive cancer develops.
- Early cancers can be cured by endoscopy — a tumour confined to the mucosa is removed through the scope, without an operation, which means the benefit of finding it early is large rather than marginal.
- The test is direct — endoscopy sees the lining itself and takes a biopsy at the same sitting, rather than inferring disease from a distant image.
- The yield depends on prevalence — which is why the recommendation is targeted. In a high-incidence region, the number of examinations needed to find one treatable lesion is small; in a low-incidence population, it is large.
Screening in high-incidence regions
Where incidence is high, endoscopic screening is a public health measure rather than an individual choice, and the practical details are worth knowing for anyone from such a region:
- Who is offered it — adults in high-incidence areas, commonly from around the age of 40 to 45, and people with a family history or a predisposing condition such as achalasia or previous caustic injury.
- What is done — endoscopy with Lugol's iodine chromoendoscopy, which makes early squamous lesions visible as unstained patches against a stained background.
- What is found — high-grade dysplasia and early carcinoma, which can then be treated by endoscopic resection at the same stage rather than by an operation or chemoradiotherapy later.
- How often — intervals vary between programmes and by the findings; a normal examination in a person at moderate risk does not need to be repeated every year, while dysplasia or a treated lesion requires closer follow-up.
- Screening is not the same as diagnosis — someone with difficulty swallowing needs a diagnostic endoscopy now, whatever their screening history.
For a patient from a high-incidence region now living elsewhere, the useful question is whether their clinician knows that background — screening that makes sense in the region of origin may not be routine in the country of residence.
Surveillance for Barrett's oesophagus
For adenocarcinoma, prevention works through finding and treating dysplasia in Barrett's mucosa, and the surveillance protocol is defined rather than discretionary:
- Biopsies at defined levels — taken from four quadrants at regular intervals along the Barrett's segment, rather than from whatever looks abnormal, because dysplasia is often invisible and focal.
- The interval follows the grade — non-dysplastic Barrett's is usually surveyed at intervals of several years; low-grade dysplasia more frequently; high-grade dysplasia is treated rather than watched.
- Treatment of dysplasia — endoscopic resection of visible lesions, with radiofrequency ablation for flat dysplasia over a longer segment, which removes the abnormal lining and allows normal squamous mucosa to regrow.
- Acid suppression — proton pump inhibitors control reflux symptoms and are part of management, though they do not by themselves remove the need for surveillance.
- Weight and reflux control — weight reduction reduces reflux and is associated with a lower risk of progression, and it is worth doing for its own sake regardless.
The most important practical point is that the interval is part of the treatment: the commonest reason for a late diagnosis in Barrett's patients is an interval that was allowed to lapse.
If a relative has had esophageal cancer
A family history changes advice in two directions, and it is worth being specific about which applies.
Where the family comes from a high-incidence region, the family history is partly a marker of shared exposure and partly of shared susceptibility, and the useful action is to enter endoscopic screening at the recommended age rather than to wait for symptoms. Where several first-degree relatives have been affected, screening is a reasonable discussion to have with a gastroenterologist even outside a formal programme.
Where a predisposing condition runs in the family — achalasia or an inherited condition affecting the oesophagus — the surveillance recommendation follows from that condition and should be managed by the specialist looking after it. And where a relative has had a squamous carcinoma of the head or neck, the oesophagus is part of the field that was exposed, which is why examination of the oesophagus is included in their follow-up and may be relevant to the family as well.
Tobacco, alcohol, temperature and diet
The measures available are few, and they are more useful stated plainly than padded out into a long list:
- Not smoking — the risk falls after stopping, and the benefit extends beyond this cancer. For squamous carcinoma in combination with alcohol it is the single most consequential change.
- Limiting alcohol, and taking the flushing response seriously — in people who flush, the same intake carries a higher risk, and the sensible course is to drink less rather than to accept the risk as unavoidable.
- Letting hot drinks cool — the IARC classification concerns beverages above roughly 65°C, and the habit to change is the temperature rather than the drink.
- Reducing pickled and mould-contaminated food, and eating more fresh fruit and vegetables — the pattern is associated with lower risk, and it is the pattern rather than any single food that the evidence supports.
- Controlling weight and reflux — relevant to adenocarcinoma, and worth doing for its own reasons as well.
None of these is a guarantee, and none of them substitutes for endoscopy in someone who has symptoms or who belongs to a surveillance group. They change the odds modestly; surveillance changes them concretely.
What screening and prevention cannot do
Being clear about the limits protects patients from two errors — assuming a normal examination provides lasting protection, and assuming that a low-risk lifestyle means no examination is needed.
- A normal endoscopy does not protect for life — a new lesion can develop later, particularly in someone who continues to smoke or drink, which is why intervals exist.
- Screening can miss a lesion — flat lesions in particular, and those hidden behind a stricture. Chromoendoscopy reduces this but does not eliminate it.
- Endoscopy carries a small risk — perforation and bleeding are uncommon but real, and sedation has its own considerations.
- Screening does not apply to everyone — in a low-incidence population without risk factors, the balance of benefit and harm does not favour routine examination.
- Prevention is not the same as avoidance — most people who develop this cancer have at least one recognised risk factor, but many have none that they could have changed.
A plan you can act on
Laid out as actions rather than as a list of risks:
- If you smoke, ask for help to stop, and if you drink heavily, ask what a realistic reduction looks like — the two together carry the greatest risk.
- If you flush when you drink, treat that as information about your risk rather than as a social detail.
- Let very hot drinks stand until they are comfortable; the change takes minutes and costs nothing.
- If you come from a high-incidence region, or have several close relatives with the disease, ask about endoscopic screening and at what age it should begin.
- If you have been told you have Barrett's oesophagus, ask what your surveillance interval is, what grade it is based on, and who is tracking it.
- If you have achalasia or have swallowed a caustic substance, ask whether surveillance endoscopy is recommended for you and from when.
- If swallowing changes, ask for endoscopy rather than waiting for the next scheduled examination.
Each of these is a specific question with a specific route, and together they cover nearly all of what can usefully be done about this cancer before it produces symptoms.